NuvOx Therapeutics, Inc. (NUOX)

NuvOx Therapeutics will go public soon, but the exact IPO date is still unknown.

IPO Price Range

$6.00 - $8.00

Shares Offered

2,860,000

Deal Size

$20.02M

NuvOx Therapeutics Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Revenue	1.04	0.98	0.51
Revenue Growth	-	91.41%	-
Gross Profit	1.04	0.98	0.51
Operating Income	-4.46	-5.1	-4.82
Net Income	-11.81	-17.21	-7.27

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Cash & Investments	0.27	0.13	1.66
Total Debt	27.88	22.76	10.61
Net Cash (Debt)	-27.61	-22.63	-8.96
Net Cash Growth	-	-	-

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Operating Cash Flow	-1.78	-2.07	-3.74
Capital Expenditures	0	-	-0.01
Free Cash Flow	-1.78	-2.07	-3.74
Free Cash Flow Growth	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Gross Margin	100.00%	100.00%	100.00%
Operating Margin	-430.53%	-520.71%	-941.02%
Pretax Margin	-1140.97%	-1756.53%	-1419.53%
Profit Margin	-1140.97%	-1756.53%	-1419.53%
FCF Margin	-171.88%	-211.33%	-730.86%